KBC Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $33.9M | Buy |
423,024
+51,266
| +14% | +$4.23M | 0.09% | 205 |
|
|
2025
Q4 | $31.7M | Sell |
371,758
-107,030
| -22% | -$8.78M | 0.07% | 209 |
|
|
2025
Q3 | $37.2M | Sell |
478,788
-411
| -0.1% | -$32.1K | 0.09% | 192 |
|
|
2025
Q2 | $37.5M | Buy |
479,199
+486
| +0.1% | +$36.2K | 0.1% | 192 |
|
|
2025
Q1 | $34.7M | Sell |
478,713
-169,129
| -26% | -$12.1M | 0.11% | 196 |
|
|
2024
Q4 | $48M | Sell |
647,842
-248,320
| -28% | -$17.4M | 0.13% | 152 |
|
|
2024
Q3 | $59.1M | Buy |
896,162
+104,499
| +13% | +$7.59M | 0.18% | 111 |
|
|
2024
Q2 | $73.1M | Buy |
791,663
+52,846
| +7% | +$4.68M | 0.22% | 89 |
|
|
2024
Q1 | $70.6M | Sell |
738,817
-817,836
| -53% | -$68.7M | 0.22% | 99 |
|
|
2023
Q4 | $119M | Sell |
1,556,653
-206,996
| -12% | -$14.4M | 0.42% | 50 |
|
|
2023
Q3 | $122M | Buy |
1,763,649
+179,398
| +11% | +$14.4M | 0.5% | 39 |
|
|
2023
Q2 | $149M | Buy |
1,584,251
+339,208
| +27% | +$29.5M | 0.61% | 33 |
|
|
2023
Q1 | $103M | Buy |
1,245,043
+275,999
| +28% | +$21.7M | 0.44% | 50 |
|
|
2022
Q4 | $72.3M | Sell |
969,044
-155,336
| -14% | -$12M | 0.35% | 64 |
|
|
2022
Q3 | $92.9M | Buy |
1,124,380
+102,216
| +10% | +$9.84M | 0.48% | 46 |
|
|
2022
Q2 | $97.2M | Buy |
1,022,164
+358,045
| +54% | +$37.1M | 0.48% | 47 |
|
|
2022
Q1 | $78.2M | Sell |
664,119
-366,482
| -36% | -$41.1M | 0.31% | 84 |
|
|
2021
Q4 | $134M | Sell |
1,030,601
-204,989
| -17% | -$23.9M | 0.44% | 53 |
|
|
2021
Q3 | $140M | Sell |
1,235,590
-1,060,220
| -46% | -$121M | 0.51% | 41 |
|
|
2021
Q2 | $238M | Sell |
2,295,810
-39,800
| -2% | -$3.75M | 0.43% | 54 |
|
|
2021
Q1 | $195M | Buy |
2,335,610
+167,114
| +8% | +$14.1M | 0.4% | 57 |
|
|
2020
Q4 | $1.08B | Buy |
2,168,496
+261,922
| +14% | +$21.7M | 0.46% | 48 |
|
|
2020
Q3 | $152M | Sell |
1,906,574
-14,454
| -0.8% | -$1.13M | 0.45% | 48 |
|
|
2020
Q2 | $133M | Buy |
1,921,028
+1,007,711
| +110% | +$71.6M | 0.44% | 42 |
|
|
2020
Q1 | $57.4M | Buy |
913,317
+354,891
| +64% | +$25.6M | 0.48% | 39 |
|
|
2019
Q4 | $43.4M | Buy |
558,426
+37,353
| +7% | +$2.92M | 0.27% | 85 |
|
|
2019
Q3 | $38.2M | Buy |
521,073
+14,535
| +3% | +$1.02M | 0.28% | 79 |
|
|
2019
Q2 | $31.2M | Buy |
506,538
+93,198
| +23% | +$5.64M | 0.24% | 99 |
|
|
2019
Q1 | $26.4M | Sell |
413,340
-117,273
| -22% | -$6.69M | 0.22% | 109 |
|
|
2018
Q4 | $27.1M | Sell |
530,613
-348,933
| -40% | -$17.7M | 0.3% | 77 |
|
|
2018
Q3 | $51M | Buy |
879,546
+210,054
| +31% | +$10.3M | 0.39% | 58 |
|
|
2018
Q2 | $32.5M | Buy |
669,492
+279,318
| +72% | +$13M | 0.28% | 86 |
|
|
2018
Q1 | $18.1M | Buy |
390,174
+40,455
| +12% | +$1.76M | 0.17% | 159 |
|
|
2017
Q4 | $13.1M | Sell |
349,719
-1,116
| -0.3% | -$41K | 0.11% | 225 |
|
|
2017
Q3 | $12.8M | Buy |
350,835
+56,226
| +19% | +$2.14M | 0.12% | 212 |
|
|
2017
Q2 | $11.6M | Buy |
294,609
+135,318
| +85% | +$4.94M | 0.11% | 219 |
|
|
2017
Q1 | $5M | Sell |
159,291
-118,092
| -43% | -$3.7M | 0.05% | 403 |
|
|
2016
Q4 | $8.66M | Buy |
277,383
+139,719
| +101% | +$4.53M | 0.09% | 282 |
|
|
2016
Q3 | $5.53M | Buy |
137,664
+11,898
| +9% | +$448K | 0.07% | 321 |
|
|
2016
Q2 | $4.18M | Sell |
125,766
-72,966
| -37% | -$2.5M | 0.06% | 349 |
|
|
2016
Q1 | $5.84M | Sell |
198,732
-194,061
| -49% | -$5.35M | 0.1% | 258 |
|
|
2015
Q4 | $10.3M | Buy |
392,793
+185,979
| +90% | +$4.83M | 0.19% | 147 |
|
|
2015
Q3 | $4.9M | Sell |
206,814
-712,098
| -77% | -$17.2M | 0.1% | 251 |
|
|
2015
Q2 | $21.8M | Buy |
918,912
+143,478
| +19% | +$3.24M | 0.28% | 97 |
|
|
2015
Q1 | $18.4M | Buy |
775,434
+273,972
| +55% | +$6.15M | 0.24% | 115 |
|
|
2014
Q4 | $10.6M | Sell |
501,462
-164,952
| -25% | -$3.31M | 0.13% | 190 |
|
|
2014
Q3 | $11.3M | Buy |
666,414
+201,180
| +43% | +$3.18M | 0.4% | 43 |
|
|
2014
Q2 | $6.66M | Buy |
465,234
+351,528
| +309% | +$4.77M | 0.08% | 323 |
|
|
2014
Q1 | $1.41M | Sell |
113,706
-155,646
| -58% | -$1.8M | 0.02% | 574 |
|
|
2013
Q4 | $2.95M | Buy |
269,352
+41,778
| +18% | +$471K | 0.04% | 415 |
|
|
2013
Q3 | $2.64M | Buy |
227,574
+123,342
| +118% | +$1.44M | 0.04% | 439 |
|
|
2013
Q2 | $1.17M | Buy |
+104,232
| New | +$1.23M | 0.02% | 640 |
|
Other funds holding EW
VCM
VPM
KBC Group's EW Position: Q1 2026 in Review
KBC Group increased its Edwards Lifesciences (EW) stake by 14% in Q1 2026, buying an estimated $4.23M and bringing the position to 423,024 shares worth $33.9M. The position accounts for 0.09% of the portfolio, ranked #205.
KBC Group first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.08B in Q4 2020. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- KBC Group held 423,024 shares of Edwards Lifesciences worth $33.9M as of Q1 2026.
- KBC Group bought 51,266 Edwards Lifesciences shares in Q1 2026, an estimated $4.23M.
- Edwards Lifesciences made up 0.09% of KBC Group's portfolio in Q1 2026, its #205 holding.
- KBC Group first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
- KBC Group's Edwards Lifesciences position peaked at $1.08B in Q4 2020.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.